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Female sex mitigates motor 
and behavioural phenotypes 
in TDP┽ぱばQばばのK knock┽in mice
Jodie Watkinsの┸ば┸ Anshua Ghoshは┸ば┸ Amy F┻ A┻ Keerieの┸ James J┻ P┻ Alixの┸ Richard J┻ Meadの* ┃ 
Jemeen Sreedharanは*
Amyotrophic lateral sclerosis ゅALSょ and frontotemporal dementia ゅFTDょ are overlapping 
neurodegenerative disorders┻ ALS is more commonly seen in men than women and the same may be 
the case for FTD┻ Preclinical models demonstrating sex┽speciボc vulnerability may help to understand 
female resistance to ALS┽FTD and thereby identify routes to therapy┻ We previously characterised a 
TDP┽ぱばQばばのK knock┽in mouse┸ which demonstrated behavioural phenotypes reminiscent of ALS┽FTD 
in males┻ Here we present our behavioural observations of female TDP┽ぱばQばばのK mutants┻ Female 
TDP┽ぱばQばばのK knock┽in mice displayed increased weight relative to wild┽type and increased food intake 
at はね months of age┸ much later than previously observed in male mutants┻ Spontaneous digging 
behaviour was initially normal and only declined in mutants in the second year of life┻ Gait analysis 
using Catwalk ゅhttps ┺【【www┻noldu s┻com【catwa lk┽xtょ found signiボcant deボcits in the second year of 
life┸ while nocturnal running behaviour was attenuated from ｆ はひね days of life┻ These results indicate 
that while female TDP┽ぱばQばばのK knock┽in mice do display progressive behavioural phenotypes┸ these are 
less severe than we previously noted in male mutants┻ Further studies of male and female TDP┽ぱばQばばのK 
knock┽in mice may help to unravel the mechanisms underlying sex┽speciボc vulnerability in ALS┽FTD┻
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are neurodegenerative disorders with 
shared clinical, neuropathological and genetic features, indicating that they lie on a  continuum1–3. While pure 
ALS is characterised by motor impairment, including weakness, FTD is deined by cognitive and behavioural 
dysfunction. A greater understanding of the mechanisms driving neurodegeneration is needed if we are to 
develop therapies for these devastating conditions.
Interestingly, ALS has long been recognised to disproportionately afect males. Both the incidence and preva-
lence of ALS are greater in men than in women and men also have a younger age of  onset4–6. here are also 
phenotypic diferences between the sexes, with a predominance of limb onset ALS in men and bulbar onset in 
 women4,6. Epidemiological studies of FTD are fewer in number and smaller in scale, making its sex-speciic 
efects more diicult to determine. However, a handful of studies suggest that FTD is more prevalent in  males7,8, 
and can cause more brain hypometabolism in men when the severity of cognitive symptoms is controlled  for9. 
hese efects can, however, vary between geographical  populations10–12. Bulbar onset ALS together with cogni-
tive impairment speciically shows an overwhelmingly male  predominance13. Taken together, these observations 
indicate an important but undeined role for biological sex in dictating the speciic phenotype as well as the risk 
of developing diseases of the ALS-FTD spectrum.
Almost all patients with ALS, and 50% of all FTD cases, are characterised neuropathologically by nuclear 
clearing and cytoplasmic mislocalisation of the 43-kDa transactive response DNA-binding protein (TDP-43)14,15. 
Over 50 disease-associated mutations have been found in TARDBP, the gene encoding TDP-43, which account 
for ~ 5% of fALS, < 1% of sALS, and rare familial cases of  FTD16–19. he majority of these mutations are clustered 
in the glycine-rich C-terminal  domain20 and, interestingly, some show greater penetrance in men than  women21. 
Although the roles of TDP-43 in disease development are elusive, the use of preclinical models that recapitulate 
aspects of human disease have helped to deine key underlying mechanisms. While transgenic approaches may 
be confounded by artefacts caused by spatiotemporal patterns and levels of expression that do not faithfully 
recapitulate the normal biology of a protein, recently developed knock-in models that manipulate endogenous 
alleles are more likely to accurately represent the human  condition22. We recently characterised a TDP-43Q331K 
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knock-in mouse model of ALS-FTD harbouring only a human equivalent missense mutation in the endogenous 
murine Tardbp  gene23. In our analysis of breeding ratios, we found that while female TDP-43Q331K knock-in 
mutants were present at Mendelian ratios, male mutants were under-represented. his suggested that males were 
more susceptible to deleterious efects of the TDP-43Q331K  mutation23. We subsequently focussed our attention 
on male mice, inding that male mutants displayed FTD-like  deicits23, including executive dysfunction, weight 
gain due to  hyperphagia24, and reduced digging behaviour suggestive of  apathy25. However, whether similar 
phenotypes occurred in female mutants and whether these are attenuated, as they are in women compared to 
men, was not determined.
Here, we present results from a longitudinal study to investigate behaviour in female homozygous mutant 
(TDP-43Q331K/Q331K) knock-in mice and wild-type littermates. Given the increased incidence and severity of 
ALS-FTD in  men4–7, and the increased penetrance of TARDBP mutations in  males21, we tested the hypothesis 
that female sex attenuates disease caused by mutant TDP-43Q331K.
Results
Weight gain and age┽dependent increase in food intake in female mutant mice┻ We previ-
ously showed that male TDP-43Q331K/Q331K mice displayed increased weight gain from 8 months of age and were 
also hyperphagic compared to wild-type  mice23. We therefore weighed female wild-type and TDP-43Q331K/
Q331K mice but found that at 8 months of age there were no signiicant diferences in weight (23.0 ± 1.7 g and 
25.7 ± 3.8  g, respectively, P = 0.9692). However, TDP-43Q331K/Q331K mice gradually gained more weight over 
time and were signiicantly heavier than wild-type mice from 13 months of age. By 20 months, wild-type mice 
weighed 29.5 ± 5.0 g and TDP-43Q331K/Q331K mice weighed 45.6 ± 7.7 g (P < 0.01; mixed-efects analysis) (Fig. 1a). 
To determine if weight gain in the TDP-43Q331K/Q331K mice could be due to hyperphagia, food intake was meas-
ured when mice were 9, 13 and 20 months old. he amount of food eaten in 72 h did not change with age and 
there was no signiicant diference between groups, although at 20 months there was a trend towards increased 
food intake (Fig. 1b). Wild-type and TDP-43Q331K/Q331K mice ate 12.7 ± 2.3 g and 12.3 ± 2.2 g of food at 9 months 
of age (P = 0.9801), 12.2 ± 2.3 g and 11.8 ± 1.6 g of food at 13 months of age (P = 0.9633) and 11.4 g ± 1.5 g and 
13.9 ± 2.8 g at 20 months (P = 0.0601 two-way ANOVA), respectively.
Age┽dependent deボcits in marble burying behaviour in mutant females┻ A subset of male TDP-
43Q331K/Q331K mice were previously found to display reduced spontaneous digging as determined by the mar-
ble burying assay from as early as 5 months of  age23. his may relect apathy or reduced motivation, both of 
which are features of  FTD25. We therefore examined marble burying behaviour in female wild-type and TDP-
43Q331K/Q331K mice from 8 to 20 months of age but found no signiicant diferences between genotypes at any 
given age although there was a trend towards reduced digging from 14 months onwards (Fig. 1c). At 9 months 
of age, wild-type mice buried 8.5 ± 1.4 marbles and TDP-43Q331K/Q331K mice buried 8.9 ± 0.7 marbles (P = 0.9966), 
whereas at 14 months wild-type mice buried 8.4 ± 1.2 marbles and TDP-43Q331K/Q331K mice buried 6.2 ± 2.9 mar-
bles (P = 0.0495). When mice reached 20  months of age wild-type mice buried 7.75 ± 1.6 marbles and TDP-
43Q331K/Q331K mice buried 6.4 ± 2.7 marbles (P = 0.5513, mixed-efects analysis). hese results indicate that innate 
exploratory digging behaviours are largely intact in female mutant mice, although they may be afected in older 
age.
Gait deボcits in aged mutant females┻ Our previous study showed that male TDP-43Q331K/Q331K mice 
have reduced Rotarod performance from ~ 6 months of age, which was likely due to increased body weight rather 
than impaired motor  coordination23. To test for motor coordination in female mice, we carried out detailed gait 
analysis using the Catwalk gait analysis system (Noldus, https ://www.noldu s.com/catwa lk-xt). TDP-43Q331K/Q331K 
mice had normal hindlimb base of support (BOS, the distance between the hind paws during the step cycle) 
from 8 to 14 months of age, but signiicantly wider hindlimb BOS at 20 months of age, when compared to wild-
type mice (26.9 ± 5.3 mm and 23.5 ± 2.6 mm, respectively; overall P < 0.05, two-way ANOVA) (Fig. 2a). While 
this could be due to impaired motor coordination it could also be explained by the increased body weight.
TDP-43Q331K/Q331K mice also showed decreased hindlimb swing time (time between successive paw place-
ments) and increased swing speed (average speed of paw travelling during the swing phase). he hindlimb swing 
time and swing speed of wild-type mice at 20 months were 0.09 ± 0.01 s and 0.65 ± 0.12 m/s, respectively, and 
were 0.07 ± 0.01 s and 0.83 ± 0.16 m/s for TDP-43Q331K/Q331K mice. his suggests that TDP-43Q331K/Q331K mice walk 
faster than wild-type mice (Fig. 2b, c). However, the overall duration of the runs and hindlimb stride length 
showed no signiicant diference between the two groups at 20 months of age (data not shown). Together with 
swing speed and time, these results suggest that TDP-43Q331K/Q331K mice take faster steps than wild-type mice.
Under normal conditions mice walk in a diagonal stepping pattern with only two diagonally opposed paws 
on the surface at any one  time26. An increase in the percentage of time spent on 3 or 4 paws indicates instabil-
ity whilst walking. Female wild-type mice spent the majority of their time on diagonal paws, and relatively 
little time on 3 and 4 paws from 10 to 20 months of age (Fig. 2d–f). In contrast, TDP-43Q331K/Q331K mice spent 
signiicantly more time on 3 and 4 paws (Fig. 2 d–f). his diference was most pronounced at 20 months of age, 
by which time wild-type mice were spending 71.4 ± 8.8% of time on diagonal paws and 5.04 ± 4.1% of time on 
4 paws, whereas mutants spent 58.1 ± 8.1% of time on diagonal paws and 14.1 ± 5.6% of time on 4 paws. hese 
changes indicate that TDP-43Q331K/Q331K mice stand for longer durations of the step cycle and may develop a less 
steady gait with age.
Reduced running in mutant mice┻ To gain further insight into the motor performance of female TDP-
43Q331K/Q331K mice we measured voluntary wheel running, an assay that can be performed without disruption to 
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the normal murine diurnal rhythm in a minimally stressful  environment27. Behaviour was monitored daily in 
mice that had unlimited access to a running wheel, which was linked to a sensor to measure time spent running, 
total distance run, and speed. As they aged, both wild-type and TDP-43Q331K/Q331K mice showed a progressive 
decline in total time and distance run per night, but this deterioration was more marked in mutants (Fig. 3a, b). 
Wild-type mice had a decrease from 286 ± 102 to 109 ± 56 min of running per night and mutants had a decrease 
from 252 ± 107 to 33 ± 30 min of running per night between 8 and 20 months of age (overall P < 0.0001, two-way 
ANOVA). Wild-type mice retained their average speed from 250 to 600 days of age, but mutants declined over 
time and became signiicantly slower. By 20 months of age wild-type mice were running 2.2 ± 1.81 km per night 
at 1.12 ± 0.35 km/h, whereas TDP-43Q331K/Q331K mice were running 0.50 ± 0.61 km per night at 0.68 ± 0.38 km/h 
(Fig.  3c). his suggests that female TDP-43Q331K/Q331K mice have reduced physical performance compared to 
wild-types.
Preservation of functional motor units in mutant mice┻ To determine if the motor deicits in female 
mutants were due to neuromuscular dysfunction, we looked for evidence of denervation by measuring com-
pound muscle action potentials (CMAP) in the hindlimbs of 12-month-old mice. However, we found no signii-
cant diferences in CMAP amplitudes between wild-type and mutant females (36.5 ± 5.4 mV and 39.2 ± 8.9 mV, 
respectively; n = 3 per genotype; P = 0.6689, unpaired t-test) (Fig. 4). his suggests that functional motor units 
are preserved in mutant mice and that the motor deicits they display are not due to neuromuscular denerva-
tion. Nonetheless, a more detailed analysis with a larger sample size and at more timepoints may be of value in 
determining if female mutants are vulnerable to denervation.
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Figure 1.  Female TDP-43Q331K/Q331K mice show marked weight gain over time, and age-dependent trends 
towards increased food intake and reduced marble burying. (a) Body weight from 8 to 21 months of age 
(n = 6–10 wild-type, 8–10 mutants) is signiicantly increased in mutants (overall P = 0.0005; mixed-efect 
analysis). (b) Food intake at 9, 13 and 20 months of age (n = 10 per genotype (9 months); 9 wild-type, 8 mutants 
(13 months); 8 wild-type, 9 mutants (20 months)) (overall P = 0.3260; two-way ANOVA). (c) Marble burying 
from 8 to 20 months of age (n = 10 per genotype (8, 9, 10 and 12 months); 9 per genotype (14 months); 8 per 
genotype (20 months)) shows no signiicant diference between groups (P = 0.6689; unpaired t-test). Error bars 
represent mean ± s.e.m, except in (c) where they are median ± interquartile range. ***P < 0.001.
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Discussion
Epidemiological studies show that women are signiicantly less likely to develop ALS-FTD than men. Preclinical 
models of ALS-FTD that recapitulate this sex diference could help to understand the reasons for the protec-
tion conferred by female sex, which may in turn help towards developing therapies. In this study we found that 
female TDP-43Q331K knock-in mice develop motor and behavioural deicits similar to those previously observed 
in male mutants, but that these phenotypes were less severe in females (Table 1). he clearest indicator of this 
was the striking weight gain seen in mutants, which occurred later in life and to a lesser extent in females than 
in males. Similarly, while food intake and marble burying behaviour were signiicantly increased and decreased 
respectively in male mutants, female mutants showed only trends towards such changes. he gradual increase 
in weight gain in both male and female TDP-43Q331K/Q331K mice may be attributable to the role of TDP-43 in fat 
metabolism regulated by Tbc1d128,29, which is most likely independent of  oestrogen30. However, the hyperphagia 
observed in female mice at 20 months when oestrogen levels have  dropped31 may directly result from release 
of the appetite stimulating gut hormone ghrelin, normally under tonic inhibition by  oestradiol32. hus, further 
studies of TDP-43Q331K mice promise to help unravel how female sex protects against ALS-FTD.
Determining diferences due to biological sex in other animal models of ALS/FTD is more challenging due to 
confounding factors such as genetic background and transgene expression levels. Nonetheless, some studies have 
reported sex-speciic behavioural diferences in mouse models of ALS and FTD. A transgenic TDP-43A315T mutant 
mouse shows earlier disease onset and more rapid disease progression in males than females, accompanied by 
reduced  lifespan33, although females perform worse in spatial learning  tasks34. Female TDP-43M323K knock-in 
mice harbouring a missense mutation in the endogenous Tardbp gene display an age-dependent decrease in grip 
strength, while males are  normal35. Mouse models of other ALS and FTD-linked genes present a more complex 
picture. Males overexpressing human mutant superoxide dismutase 1  (SOD1G93A) show earlier disease onset than 
 females36, although this is dependent on genetic  background37,38. However, the opposite is observed in females 
harbouring an inducible D83G point mutation in murine Sod1, which demonstrate earlier impairment in Rotarod 
performance, though males reach end-stage  sooner39. Female  SOD1G37R mice also have increased maladaptive 
axonal arborisation compared to males, which corresponds to neuronal loss and muscular  denervation40. In 
contrast, transgenic female mice expressing the G118V mutation in proilin1 (PFN1) reach end-stage earlier 
than males, although age of disease onset is unafected by  sex41. Similarly, female transgenic mice expressing a 
mutant form of chromosome 9 open reading frame 72 (C9ORF72), the most common known genetic cause of 
ALS-FTD3, have reduced body weight while male mutants are  unafected42. his suggests an intricate regulation 
of sex-speciic behaviours in diverse animal models.
Genetic studies in humans also suggest that biological sex inluences the phenotype of both ALS and FTD. 
Mutations in TARDBP, while rare, appear to be more penetrant in male than female  patients21. Conversely, 
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Figure 2.  Catwalk gait analysis of female wild-type and TDP-43Q331K/Q331K mice shows gait deicits in 
aged mutants. (a) Hindlimb base of support (BOS) (P < 0.05; two-way ANOVA). (b) Hindlimb swing time 
(P < 0.0001; two-way ANOVA). (c) Hindlimb swing speed (P < 0.05; two-way ANOVA). (d) Percentage of 
diagonal walking (P < 0.05; two-way ANOVA). (e) Percentage of 3-paw walking (P < 0.01; two-way ANOVA). 
(f) Percentage of 4-paw walking (P < 0.05 at 20 months on multiple comparisons; two-way ANOVA). All data 
is from 8 to 20 months of age (n = 10 per genotype (8 months); 10 wild-type, 9 mutants (10 and 12 months); 9 
per genotype (14 months); 9 wild-type, 7 mutants (20 months)). Error bars represent mean ± s.e.m. *P < 0.05, 
**P < 0.01, ****P < 0.0001.
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mutations in C9ORF72 have been shown to be more commonly seen in women than men with  ALS43, although 
this diference is not observed in C9ORF72-related  FTD43. Mutations in progranulin (GRN) are also more com-
mon in  women43, and mutations in T-cell restricted intracellular antigen 1 (TIA1) have, to date, been found 
exclusively in  women44. Mutations in microtubule-associated protein tau (MAPT) by contrast are not speciic to 
either  sex43.
A likely explanation for sex diferences in neurodegenerative disease is the role of reproductive hormones. 
Oestrogens, speciically 17β-oestradiol, can exert neuroprotective efects in both males and females by signalling 
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Figure 3.  Running wheel analysis of female wild-type and TDP-43Q331K/Q331K mice shows reduced running in 
mutants. (a) Time run per 24 h (P < 0.0001; two-way ANOVA). (b) Distance run per 24 h (P < 0.0001; two-way 
ANOVA). c Mean speed run per 24 h (P < 0.0001; two-way ANOVA). All data are from 230 to 618 days of age 
(n = 8–10 wild-type, 7–10 mutants). Error bars represent mean ± s.e.m. ****P < 0.0001.
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through oestrogen receptors, which are widely distributed in the  brain45. hese efects range from maintenance 
of cognition and response to injury, to dendritic spine maturation and adult  neurogenesis46. his is in keeping 
with indings from patients with ALS in whom the sex diferences in incidence and prevalence diminish with 
 age4. his may well be due to the reduction in levels of oestrogen in post-menopausal  women5.
he protective efects of sex hormones are not only restricted to neurons, which constitutively produce oestra-
diol, but also  glia45. Astrocytes show sex diferences in their development, number and morphology, in addition 
to functional characteristics like glutamate uptake and their response to cannabinoids, gonadotrophic hormones, 
and harmful stimuli such as environmental  toxins47. Microglia, the innate immune cells of the central nervous 
system, develop sex-speciic transcriptional diferences in adulthood, although it is debated which sex develops 
a more pro-inlammatory  phenotype48. his may contribute to sex-speciic diferences in ALS-FTD, given that 
microglia play key roles during development and ageing, express high levels of the FTD-linked gene GRN49, and 
have been implicated in disease pathogenesis by several mouse models of  ALS50–52.
he efects of sex hormones on brain mitochondrial metabolism have also been well  documented53. For 
example, 17β-oestradiol can transcriptionally regulate and increase the function of components of the respira-
tory chain while reducing oxidative stress in brain mitochondria. Cerebral expression of the oestrogen receptors 
ERα and ERβ is also sexually  dimorphic53. Incidentally, female transgenic mutant SOD1 mice have delayed onset 
of mitochondrial dysfunction in the spinal cord compared to  males54, possibly resulting from ERα-dependent 
activation of the mitochondrial unfolded protein  response55. his transcriptional programme for restoration 
of proteostasis can also be activated by TDP-4356. Hormonal regulation may also afect disease course in ALS 
through regulation of the expression of a group of muscle-speciic  microRNAs57. he efects of progesterone and 
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Figure 4.  Compound muscle action potentials in 12-month-old mutant mice are no diferent to wild-type. n = 3 
per genotype. P = 0.6689, unpaired t-test. Error bars represent mean ± s.e.m.
Table 1.  Summary of diferences between male and female TDP-43Q331K mice in age of onset of behavioural 
phenotypes, compared to wild-type. a Earliest age at which food intake was measured. b Statistical trend. c As 
male mice on the C57BL/6 background have low baseline levels for this  task69.
Phenotype (compared to wild-type)
Age of onset (months)
Male23 Female
Weight gain 8 13
Increased food intake 9a 20b
Reduced marble burying 5 14b
Gait defects 6 20
Reduced running n/ac 8
Muscle denervation None None
ぴ
Vol.:(0123456789)
Scientiボc Reports |        (2020) 10:19220  | https┺【【doi┻org【のね┻のねばふ【sぱのひぶふ┽ねはね┽ぴびねぴね┽w
www.nature.com/scientificreports/
testosterone on the brain are, however, more elusive, with multiple mechanisms both conferring neuroprotection 
and enhancing  neurodegeneration58–63.
Abundant evidence indicates sexual dimorphism in varied neurodegenerative diseases. Males have a two-
fold increased risk of Parkinson’s disease, and also present with more marked non-motor symptoms compared 
to  females64. In contrast, females are more likely to develop Alzheimer’s  disease65, particularly those with the 
APOEε4  allele66, and women with Huntington’s disease show a faster rate of progression than  men67. Our indings 
add to a growing body of evidence suggesting that the inluence of biological sex in neurodegenerative diseases 
is complex, resulting not only from genetic architecture, age, epigenomic and transcriptomic factors, but also 
from the efects of reproductive hormones on glial and neuronal cells, and organelle function. We conclude that 
the TDP-43Q331K/Q331K knock-in mouse, which displays sex-speciic behavioural diferences, can be utilised as a 
tool to investigate female resistance to ALS-FTD and thereby help towards developing therapies for this disease 
spectrum.
Methods
Mouse model and genotyping┻ Mice were generated using CRISPR/Cas9 mutagenesis as described 
 previously23 and maintained on a C57BL/6J background by crossing with wild-type animals. Animals were bred 
in a speciic pathogen free environment and transferred to a conventional facility under a 12-h light/dark cycle. 
Cages (36 × 21 × 18.5 cm) were lined with ine sawdust (eco-pure lakes 6, Datesand, UK), a plastic house was 
placed in each cage and paper wool (Datesand, UK) was used as bedding material. All mice were singly housed 
due to the use of running wheels in the home cage, with food (Harlan, UK) and water available at libitum. Ani-
mals were genotyped as described  previously23. All experiments were conducted in accordance with the United 
Kingdom Animals (Scientiic Procedures) Act (1986) and the United Kingdom Animals (Scientiic Procedures) 
Act (1986) Amendment Regulations 2012, and also reviewed and approved by the University of Sheield Animal 
Welfare and Ethical Review Body (AWERB). Power calculations were determined as described  previously23. All 
of the behavioural testing was carried out on the same cohort of female mice. One wild-type and one mutant 
mouse developed skin conditions at 1 year of age and were humanely culled on compassionate grounds. One 
wild-type and one mutant mouse lost 20% of their bodyweight nearing the 20-month time point and were culled 
on compassionate grounds. One additional mutant mouse was found to be unwell at 20 months of age and was 
culled.
Body weight and food intake┻ Animals were weighed weekly in the morning as previously  described23. 
Food intake was monitored at various timepoints by weighing the food in the hopper, then re-weighing approxi-
mately 72 h later. During the 72-h period, sawdust in the cage was replaced with paper towelling to ensure any 
small pieces of food dropped from the top of the hopper could be included for weighing.
Marble burying┻ he marble burying assay was conducted as described  previously23, except that difer-
ent cages were used. Briely, all testing was conducted in the morning and blind to genotype in cages of size 
33 × 21 × 19 cm (Tecniplast) with fresh sawdust (Datesand, grade 6) placed to a height of ~ 8 cm. Ten glass mar-
bles (1 cm) were placed evenly across the bedding. A single mouse was placed in each of the cages, the lids 
replaced, and let undisturbed for 30 min under white light. Mice were then removed, and the number of mar-
bles buried by at least two thirds was scored.
Catwalk gait analysis┻ he Catwalk gait analysis system 7.1 (Noldus Information Technology B.V., Neth-
erlands, https ://www.noldu s.com/catwa lk-xt) was used to capture gait parameters at 8, 10, 12, 14, and 20 months 
of age as previously  described38. Mice were placed on the glass loor of the catwalk system in complete darkness 
and let to walk/run freely. Whenever possible, six continuous runs were recorded, with the three best runs being 
selected for analysis. Catwalk sotware 7.1 was used to label each paw print during each run and analyse the gait 
parameters of the mice.
Running wheel analysis┻ he running wheel set-up was based on an in-house protocol described 
 previously68. Each cage contained a 37.8 cm circumference Fast Trac running wheel (LBS Biotech, UK) mounted 
at 25˚ below horizontal, on a 4 cm ixed post. he wheel was placed in the corner of each cage where the circum-
ference was 5–10 mm from the edge of two perpendicular sides of the cage. A 5 × 10 mm neodymium magnet 
was glued to the underside of each Fast Trac wheel and a bicycle computer (Cateye Velo, Japan) with reed switch 
was ixed to the side of the cage. Time spent running, distance run, and average running speed were recorded 
daily.
Compound muscle action potential ゅCMAPょ amplitude testing┻ Mice were placed under gaseous 
anaesthesia (1–2% isolurane), with body temperature maintained using an electric heat pad (CWE, USA), and 
fur from the let hindlimb and lower back was removed. All recordings were made using a Dantec Keypoint 
Focus EMG System (Optima, UK) as previously  described38. A grounding electrode was placed in the base of 
the tail (Ambu Neuroline, UK), and ring recording electrodes were placed circumferentially around the distal 
hindlimb muscles (Alpine Biomed, Denmark), layered with Ten20 nerve conductive paste (Pulse Medical Ltd, 
UK). CMAPs were acquired by applying a single, square wave electrical impulse of 0.1 ms duration to the sciatic 
notch using twisted pair subdermal electrodes (Ambu Neuroline, UK). he position of the subcutaneous stimu-
lating electrodes was trialled to ensure that a response was obtained using a stimulating current of 1–2 mA. he 
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stimulation intensity was then increased until no further increase in amplitude was seen and a supramaximal 
response elicited.
Statistical analyses┻ All data was analysed using GraphPad Prism version 8 (https ://www.graph pad.com/
scien tiic -sotw are/prism /). Statistical signiicance was determined by two-way analysis of variance (ANOVA) 
with or without repeated measures with Sidak correction for multiple testing, mixed efects analysis, or Student’s 
t-test. Results having P < 0.05 were considered signiicant in every analysis.
Please note that this methods section was adapted from the PhD thesis of the irst author, which can be found 
at https ://ethes es.white rose.ac.uk/id/eprin t/16694 re-used here under a creative commons CC BY-NC-ND 2.0 
UK license (https ://creat iveco mmons .org/licen ses/by-nc-nd/2.0/uk/).
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